hero image
Olexandr Isayev - Carnegie Mellon University. Pittsburgh, PA, US

Olexandr Isayev Olexandr Isayev

Assistant Professor | Carnegie Mellon University



Working to connect artificial intelligence with chemical sciences, Olexandr Isayev's research focuses on solving fundamental chemical problems with machine learning, molecular modeling and quantum mechanics. his lab works at the interface of theoretical chemistry, pharmaceutical sciences and computer science, working in such areas as theoretical and computational chemistry, machine learning, cheminformatics, drug discovery, computer-aided molecular design and materials informatics.

Areas of Expertise (2)

Artificial Intelligence

Future of Science

Education (2)

Jackson State University: Ph.D., Theoretical Chemistry

Dnepropetrovsk National University: M.S., Chemistry

Media Appearances (4)

AI-Based ‘Artificial Chemist’ Directs Automated Lab to Create Better MRI Contrast Agents

HPC Wire  

Artificial-intelligence algorithm developed on XSEDE-allocated systems promises better MRI agents with unprecedented speed of discovery

view more

ALCC Program Awards Computing Time on ALCF’s Theta Supercomputer to 24 projects

HPC Wire  

The U.S. Department of Energy’s (DOE) Advanced Scientific Computing Research (ASCR) Leadership Computing Challenge (ALCC) has awarded 24 projects a total of 5.74 million node hours at the Argonne Leadership Computing Facility (ALCF) to pursue challenging, high-risk, high-payoff simulations.

view more

Chemical Discovery for Industry, Medical with Carnegie Mellon’s Neural Network Tool

Enterprise AI  

For industrial and medical companies, a central question in modern chemistry is how to identify and synthesize molecules to create useful applications. Even with high performance computing, the research is expensive both in terms of cost and computer time required for the simulations. The good news is that artificial intelligence (AI) and machine learning (ML) are revolutionizing chemical research and creating tools that can be used in a typical enterprise setting.

view more

AI identifies drug candidate in weeks

Chemical & Engineering News  

The artificial intelligence start-up Insilico Medicine has used machine learning to find credible drug candidates in a matter of weeks (Nature Biotechnology 2019, DOI: 10.1038/s41587-019-0224-x). Experts say it’s an important demonstration of what machine learning can do in drug discovery, but it isn’t a revolution.

view more